Skip to main content
. 2008 Sep 16;99(8):1226–1231. doi: 10.1038/sj.bjc.6604674

Table 3. Drug doses received and drug delivered dose intensity (dDDI).

  ECMF
CMF
Drugs % dose received Median (IQR) dose intensity % dose received Median (IQR) dose intensity
Epirubicin 99 100 (95–105) 100a 99 (99–100)
Oral Cyclophosphamide 89 88 (78–105) 88 87 (77–104)
i.v. Cyclophosphamide 96 100 (93–104) 96 100 (92–104)
Methotrexate 97 99 (92–104) 97 99 (91–104)
5-FU 97 99 (93–104) 97 99 (91–104)
a

Based on two CMF patients who received Epirubicin through protocol violations.